Format
Sort by
Items per page

Send to

Choose Destination

Links from Nucleotide

Items: 1 to 20 of 821

1.

Genetic and epigenetic alterations affecting PARK-2 expression in cervical neoplasm among North Indian patients.

Naseem A, Bhat ZI, Kalaiarasan P, Kumar B, Gandhi G, Rizvi MMA.

Tumour Biol. 2017 Jun;39(6):1010428317703635. doi: 10.1177/1010428317703635.

PMID:
28631565
2.

Architecture of the human interactome defines protein communities and disease networks.

Huttlin EL, Bruckner RJ, Paulo JA, Cannon JR, Ting L, Baltier K, Colby G, Gebreab F, Gygi MP, Parzen H, Szpyt J, Tam S, Zarraga G, Pontano-Vaites L, Swarup S, White AE, Schweppe DK, Rad R, Erickson BK, Obar RA, Guruharsha KG, Li K, Artavanis-Tsakonas S, Gygi SP, Harper JW.

Nature. 2017 May 25;545(7655):505-509. doi: 10.1038/nature22366. Epub 2017 May 17.

3.

Parkin-phosphoubiquitin complex reveals cryptic ubiquitin-binding site required for RBR ligase activity.

Kumar A, Chaugule VK, Condos TEC, Barber KR, Johnson C, Toth R, Sundaramoorthy R, Knebel A, Shaw GS, Walden H.

Nat Struct Mol Biol. 2017 May;24(5):475-483. doi: 10.1038/nsmb.3400. Epub 2017 Apr 17.

PMID:
28414322
4.

Inactivation of parkin by promoter methylation correlated with lymph node metastasis and genomic instability in nasopharyngeal carcinoma.

Ni H, Zhou Z, Jiang B, Yuan X, Cao X, Huang G, Li Y.

Tumour Biol. 2017 Mar;39(3):1010428317695025. doi: 10.1177/1010428317695025.

PMID:
28351314
5.

A comprehensive computational study on pathogenic mis-sense mutations spanning the RING2 and REP domains of Parkin protein.

Biswas R, Bagchi A.

Gene. 2017 Apr 30;610:49-58. doi: 10.1016/j.gene.2017.02.008. Epub 2017 Feb 9.

PMID:
28189762
6.

Efficient induction of dopaminergic neuron differentiation from induced pluripotent stem cells reveals impaired mitophagy in PARK2 neurons.

Suzuki S, Akamatsu W, Kisa F, Sone T, Ishikawa KI, Kuzumaki N, Katayama H, Miyawaki A, Hattori N, Okano H.

Biochem Biophys Res Commun. 2017 Jan 29;483(1):88-93. doi: 10.1016/j.bbrc.2016.12.188. Epub 2017 Jan 3.

PMID:
28057485
7.

Pan-Cancer Analysis Links PARK2 to BCL-XL-Dependent Control of Apoptosis.

Gong Y, Schumacher SE, Wu WH, Tang F, Beroukhim R, Chan TA.

Neoplasia. 2017 Feb;19(2):75-83. doi: 10.1016/j.neo.2016.12.006. Epub 2016 Dec 27.

8.

Atg8 family LC3/GABARAP proteins are crucial for autophagosome-lysosome fusion but not autophagosome formation during PINK1/Parkin mitophagy and starvation.

Nguyen TN, Padman BS, Usher J, Oorschot V, Ramm G, Lazarou M.

J Cell Biol. 2016 Dec 19;215(6):857-874. Epub 2016 Nov 18.

9.

 PARK2 polymorphisms predict disease progression in patients infected with hepatitis C virus.

Al-Qahtani AA, Al-Anazi MR, Al-Zoghaibi FA, Abdo AA, Sanai FM, Al-Hamoudi WK, Alswat KA, Al-Ashgar HI, Khan MQ, Albenmousa A, Khalak H, Al-Ahdal MN.

Ann Hepatol. 2016 Nov-Dec 2016;15(6):824-833.

10.

Parkin regulates lipopolysaccharide-induced proinflammatory responses in acute lung injury.

Letsiou E, Sammani S, Wang H, Belvitch P, Dudek SM.

Transl Res. 2017 Mar;181:71-82. doi: 10.1016/j.trsl.2016.09.002. Epub 2016 Sep 13.

PMID:
27693468
11.

Dopa-responsive dystonia or early-onset Parkinson disease - Genotype-phenotype correlation.

Potulska-Chromik A, Hoffman-Zacharska D, Łukawska M, Kostera-Pruszczyk A.

Neurol Neurochir Pol. 2017 Jan - Feb;51(1):1-6. doi: 10.1016/j.pjnns.2016.07.013. Epub 2016 Sep 12.

PMID:
27667361
13.

Impulsive-compulsive behaviors in parkin-associated Parkinson disease.

Morgante F, Fasano A, Ginevrino M, Petrucci S, Ricciardi L, Bove F, Criscuolo C, Moccia M, De Rosa A, Sorbera C, Bentivoglio AR, Barone P, De Michele G, Pellecchia MT, Valente EM.

Neurology. 2016 Oct 4;87(14):1436-1441. Epub 2016 Sep 2.

14.

Mutation analysis of the PARKIN, PINK1, DJ1, and SNCA genes in Turkish early-onset Parkinson's patients and genotype-phenotype correlations.

Erer S, Egeli U, Zarifoglu M, Tezcan G, Cecener G, Tunca B, Ak S, Demirdogen E, Kenangil G, Kaleagası H, Dogu O, Saka E, Elibol B.

Clin Neurol Neurosurg. 2016 Sep;148:147-53. doi: 10.1016/j.clineuro.2016.07.005. Epub 2016 Jul 4.

PMID:
27455133
15.

Compartmentalized Regulation of Parkin-Mediated Mitochondrial Quality Control in the Drosophila Nervous System In Vivo.

Sung H, Tandarich LC, Nguyen K, Hollenbeck PJ.

J Neurosci. 2016 Jul 13;36(28):7375-91. doi: 10.1523/JNEUROSCI.0633-16.2016.

16.

High-resolution arrays reveal burden of copy number variations on Parkinson disease genes associated with increased disease risk in random cohorts.

Murthy MN, Veerappa AM, Seshachalam KB, Ramachandra NB.

Neurol Res. 2016 Sep;38(9):775-85. doi: 10.1080/01616412.2016.1204105. Epub 2016 Jul 11.

PMID:
27399248
17.

Parkin loss-of-function pathology: Premature neuronal senescence induced by high levels of reactive oxygen species?

Buhlman LM.

Mech Ageing Dev. 2017 Jan;161(Pt A):112-120. doi: 10.1016/j.mad.2016.06.008. Epub 2016 Jun 29. Review.

PMID:
27374431
18.

Hepatitis B Virus-Induced Parkin-Dependent Recruitment of Linear Ubiquitin Assembly Complex (LUBAC) to Mitochondria and Attenuation of Innate Immunity.

Khan M, Syed GH, Kim SJ, Siddiqui A.

PLoS Pathog. 2016 Jun 27;12(6):e1005693. doi: 10.1371/journal.ppat.1005693. eCollection 2016 Jun.

19.

Association of a PARK2 Germline Variant and Epithelial Ovarian Cancer in a Southern Brazilian Population.

Klimczak PF, Ventury DH, Faucz FR, Settas N, Machado de Souza C, Sotomaior VS.

Oncology. 2016;91(2):101-5. doi: 10.1159/000446657. Epub 2016 Jun 10.

20.

Involvement of PARK2-Mediated Mitophagy in Idiopathic Pulmonary Fibrosis Pathogenesis.

Kobayashi K, Araya J, Minagawa S, Hara H, Saito N, Kadota T, Sato N, Yoshida M, Tsubouchi K, Kurita Y, Ito S, Fujita Y, Takasaka N, Utsumi H, Yanagisawa H, Hashimoto M, Wakui H, Kojima J, Shimizu K, Numata T, Kawaishi M, Kaneko Y, Asano H, Yamashita M, Odaka M, Morikawa T, Nakayama K, Kuwano K.

J Immunol. 2016 Jul 15;197(2):504-16. doi: 10.4049/jimmunol.1600265. Epub 2016 Jun 8.

Supplemental Content

Support Center